Daniel Rogers Burnett
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$14.9MFederal grants as PI27 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
27 awards · $14.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 22, 2024 | NIH | SBIR Phase I SoleStim Neuromodulation System, a home-use device for the treatment of dysmenorrhea | $344K | Theranova LLC |
| Aug 24, 2023 | NIH | SBIR Phase II A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location | $653K | Theranova LLC |
| Aug 22, 2023 | NIH | SBIR Phase II A Photo-based Menstrual Blood Loss Metric | $609K | Theranova LLC |
| Aug 30, 2022 | NIH | SBIR Phase II A Photo-based Menstrual Blood Loss Metric | $722K | Theranova LLC |
| Aug 24, 2022 | NIH | SBIR Phase II A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location | $1.0M | Theranova LLC |
| Jun 30, 2022 | NIH | SBIR Phase II A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population | $576K | Theranova LLC |
| Sep 23, 2021 | NIH | SBIR Phase II A Photo-based Menstrual Blood Loss Metric | $717K | Theranova LLC |
| Jun 23, 2021 | NIH | SBIR Phase II A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population | $593K | Theranova LLC |
| Jun 14, 2021 | NIH | SBIR Phase II Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder | $910K | Theranova LLC |
| May 12, 2021 | NIH | SBIR Phase I Empower Neuromodulation System, a home-use device for the treatment of anxiety disorders | $303K | Theranova LLC |
| Nov 13, 2020 | NIH | SBIR Phase II A Non-Invasive Neuromodulation Device for In-Home Treatment of Overactive Bladder | $73K | Theranova LLC |
| Aug 26, 2020 | NIH | SBIR Phase II A Device for the Prevention and Treatment of Multiple Organ Failure in COVID-19 Patients | $399K | Theranova LLC |
| Jul 22, 2020 | NIH | SBIR Phase II A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population | $765K | Theranova LLC |
| Apr 10, 2020 | NIH | SBIR Phase II A Non-Invasive Neuromodulation Device for In-Home Treatment of Overactive Bladder | $687K | Theranova LLC |
| Sep 22, 2019 | NIH | SBIR Phase II A Non-Invasive Neuromodulation Device for In-Home Treatment of Overactive Bladder | $807K | Theranova LLC |
| Sep 17, 2019 | NIH | SBIR Phase I Non-invasive Neuromodulation Device for Decreasing Withdrawal Symptoms and Craving during Treatment of Opioid Use Disorder | $223K | Theranova LLC |
| Mar 15, 2019 | NIH | SBIR Phase I A Novel Nasogastric Feeding Tube for Optimizing Nutritional Administration in Neonatal and Pediatric Patients | $225K | Theranova LLC |
| Nov 2, 2018 | NIH | SBIR Phase II Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women | $855K | Theranova LLC |
| Sep 22, 2018 | NIH | SBIR Phase I A Novel Transurethral Cryotherapy Catheter System to Treat Benign Prostate Hyperplasia | $318K | Theranova LLC |
| Sep 18, 2018 | NIH | SBIR Phase I A Novel, Low-Cost Device to Guide Peripherally Inserted Central Catheter (PICC) Line Placement | $225K | Theranova LLC |
| Jul 31, 2018 | NIH | SBIR Phase I A Novel, Low-Cost Device to Guide Peripherally Inserted Central Catheter (PICC) Line Placement in Pediatric and Neonatal Patients | $224K | Theranova LLC |
| Nov 30, 2017 | NIH | SBIR Phase I Neural Modulation System for In-Home Treatment of Overactive Bladder | $225K | Theranova LLC |
| Nov 10, 2017 | NIH | SBIR Phase II Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women | $1.1M | Theranova LLC |
| Sep 13, 2017 | NIH | SBIR Phase I A Novel Nasogastric Feeding Tube for Optimizing Nutritional Administration in Older Adults | $225K | Theranova LLC |
| Jul 21, 2016 | NIH | SBIR Phase I Non-Invasive Device to Remotely Monitor Cardiac Function and Reduce Cost of Managing Heart Failure Patients | $309K | Theranova LLC |
| Jan 28, 2016 | NIH | SBIR Phase II A novel device for improving sepsis outcomes through hemodynamic optimization | $798K | Theranova LLC |
| Jan 19, 2015 | NIH | SBIR Phase II A novel device for improving sepsis outcomes through hemodynamic optimization | $998K | Theranova LLC |
Peer ranks
Federal funding#25
Awards as PI#10
Patents#505
Companies
- Theranova LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.